Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial

20254 citationsJournal Articlegold Open Access

Authors

Armin Ghobadi · Washington University in St. Louis

Paolo F. Caimi · Cleveland Clinic

Jane Reese · Case Comprehensive Cancer Center

Krishna Goparaju · University Hospitals of Cleveland

Martina Di Trani · IRCCS Humanitas Research Hospital

Julie Ritchey · Cleveland Clinic

Zachary Jackson

Abstract

This clinical trial was funded through University Hospitals Seidman Cancer Center and Washington University School of Medicine Institutional Funds. Correlative analyses were funded in part by the European Union-Next Generation EU-NRRP M6C2-Investment 2.1 Enhancement and strengthening of biomedical research in the NHS (project #PNRR-MAD-2022-12376059), and the Italian Ministry of Health Ricerca Finalizzata 2019 (project #RF-2019-12370243).

Topics & Keywords

CAR-T cell therapy research Viral Infectious Diseases and Gene Expression in Insects

Publication Details

Published in: EClinicalMedicine

Volume 81, pp. 103138-103138

DOI: 10.1016/j.eclinm.2025.103138

Field-Weighted Citation Impact: 4.38

Command Palette

Treatment of non-Hodgkin lymphoma with point-of-care manufactured CAR T cells: a dual institution, phase 1 trial

Authors

Abstract

Topics & Keywords

Publication Details